Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/06/2008 | US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression |
03/06/2008 | US20080058248 Toxin Complex Proteins and Genes from Xenorhabdus bovienii |
03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
03/06/2008 | US20080058245 Cloning nucleic acids coded for therapy |
03/06/2008 | US20080058222 Obtaining faithful RNA and cDNA expression libraries; extraction from intact tissue cultured in three dimensional sponge gels; tumor development prognosis |
03/06/2008 | US20080058214 Signal sequence trapping |
03/06/2008 | US20080057585 Phospolipid:diacylglycerol acyltransferases |
03/06/2008 | US20080057584 Using vector transformation to express glucose transport protein (GLUT-1) in mammalian cells; prevention and treatment of apoptosis, necrosis and proliferation inhibition |
03/06/2008 | US20080057582 Using vector comprising dihydroorotase, translation iniation factor-1a and sugar beet kinase as tool for generating drought, cold and frost resistant crop plants |
03/06/2008 | US20080057581 Ires Functioning In Plant |
03/06/2008 | US20080057575 Optimizing Expression of Active Botulinum Toxin Type A |
03/06/2008 | US20080057566 Bacterial host cell for the direct expression of peptides |
03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
03/06/2008 | US20080057564 Nucleotide sequences coding mitotic regulatory proteins for use identifying modulators of plant development |
03/06/2008 | US20080057563 Using enhanced argobacterium to transfer genetic elements into plants; improving heterologous gene expression |
03/06/2008 | US20080057560 Reagents for isolation of purified rna |
03/06/2008 | US20080057551 Enhanced Production of Lipids Containing Polyenoic Fatty Acid by Very High Density Cultures of Eukaryotic Microbes in Fermentors |
03/06/2008 | US20080057546 Generating preferentisl nuleotide seuence using adapter molecules to mediate binding between first and second molecules; gene libraries; genomic analysis |
03/06/2008 | US20080057545 Modified escherichia orgin of replication for use as tool to enhance replicative ability of vectors; improving heterologous gene expression |
03/06/2008 | US20080057540 Novel DKR polypeptides |
03/06/2008 | US20080057539 Glutamate transporter associated proteins and methods of use thereof |
03/06/2008 | US20080057538 Expression vector comprising heat shock protein for use as tool in improving heterologous gene expression; enhancing protein folding |
03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
03/06/2008 | US20080057529 Method for Identifying Histone Deacetylase Inhibitors |
03/06/2008 | US20080057522 Method for Screening Agents Modulating Ikbalpha Protein Ubiquitination and Means for Carrying out Said Method |
03/06/2008 | US20080057519 Monoclonal antibody specific for b-cell chronic lymphocytic leukemia cell surface protein; diagnosing cell proliferative disorders of blood |
03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
03/06/2008 | US20080057509 Defects in Periaxin Associated with Myelinopathies |
03/06/2008 | US20080057504 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
03/06/2008 | US20080057495 Marchantiales-Derived Unsaturated Fatty Acid Synthetase Genes And Use Of The Same |
03/06/2008 | US20080057492 Interacting site for gp41 on gp120 of hiv-1 |
03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
03/06/2008 | US20080057081 Influenza Hemagglutinin And Neuraminidase Variants |
03/06/2008 | US20080057080 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection |
03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
03/06/2008 | US20080057076 Novel fibroblast growth factors |
03/06/2008 | US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use |
03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
03/06/2008 | US20080057067 Immunogenic polypeptide fragments and vaccines; outer membrane proteins; prevention of infections including meningitis |
03/06/2008 | US20080057066 Methods and compositions for targeting relt |
03/06/2008 | US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus |
03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
03/06/2008 | US20080057063 human monoclonal antibodies; diagnostics and treatment of diseases associated with the activity and/or overproduction of alpha V beta 6; cancer |
03/06/2008 | US20080057056 Fc Variants with Increased Affinity for FcyRIIC |
03/06/2008 | US20080057036 comprising a Picornavirus capable of lytically infecting or killing a cell substantially in the absence of intercellular adhesion molecule |
03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
03/06/2008 | US20080057028 Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells |
03/06/2008 | US20080057004 Albumin-insulin fusion proteins |
03/06/2008 | US20080056945 Stuctural Body, Chip Using The Same, And Method Of Controlling Lyophilic/Lyophobic Property |
03/06/2008 | CA2697960A1 Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein |
03/06/2008 | CA2669812A1 Method for increasing resistance to pathogens in transgenic plants |
03/06/2008 | CA2666821A1 Methods for producing transgenic corn plants in a single container |
03/06/2008 | CA2666741A1 Family 6 cellulases with increased thermostability, thermophilicity, and alkalophilicity |
03/06/2008 | CA2662150A1 Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseases |
03/06/2008 | CA2662094A1 Method for evaluating compound using pkc-iota |
03/06/2008 | CA2662062A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
03/06/2008 | CA2662026A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
03/06/2008 | CA2661882A1 Laccases for pulp bio-bleaching |
03/06/2008 | CA2661848A1 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
03/06/2008 | CA2661825A1 Methods for rapidly transforming monocots |
03/06/2008 | CA2661808A1 Compositions and methods for improved protein production |
03/06/2008 | CA2661782A1 Antagonistic human light-specific human monoclonal antibodies |
03/06/2008 | CA2661599A1 Fusion proteins comprising tnf and fibritin trimerization domain |
03/06/2008 | CA2661181A1 Identifying transgenic corn plants without screening or selection |
03/06/2008 | CA2660260A1 Use of modified interleukin-8 proteins |
03/06/2008 | CA2658736A1 Method for the production of insulin-like growth factor-i |
03/05/2008 | EP1895017A2 Use of A33 antigens and JAM-IT |
03/05/2008 | EP1895010A2 Equine infectious anaemia virus (eiav) based vectors |
03/05/2008 | EP1895009A1 Polyunsaturated fatty acids in plants |
03/05/2008 | EP1895008A2 Isoprenoid biosynthesis |
03/05/2008 | EP1895007A1 DNA segments and methods for increasing polysaccharide production |
03/05/2008 | EP1895006A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
03/05/2008 | EP1895004A1 Human hippocalcin gene variant associated with cancers |
03/05/2008 | EP1895003A1 Cells expressing recombinase |
03/05/2008 | EP1895002A1 Novel trypsin family serine proteases |
03/05/2008 | EP1895001A1 Novel trypsin family serine proteases |
03/05/2008 | EP1894940A1 TNF superfamily fusion proteins |
03/05/2008 | EP1894939A1 Novel supertag and its use |
03/05/2008 | EP1894933A2 Compositions, methods and kits pertaining to luminescent compounds |
03/05/2008 | EP1894571A1 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
03/05/2008 | EP1894467A2 Use of glyphosate resistant maize lines |
03/05/2008 | EP1894214A1 Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use |
03/05/2008 | EP1894014A1 Method for selecting stable proteins in non-standard physicochemical conditions |
03/05/2008 | EP1893763A1 Sclerotinia-resistant brassica and methods for development of resistance to sclerotinia |
03/05/2008 | EP1893762A2 Novel plants |
03/05/2008 | EP1893761A2 Modulation of plant growth by altering amino acid uptake |
03/05/2008 | EP1893760A1 Plants having improved growth characteristics and method for making the same |
03/05/2008 | EP1893759A2 Methods for increasing the resistance of plants to hypoxic conditions |
03/05/2008 | EP1893758A1 Hybridization-stabilizing construct |
03/05/2008 | EP1893757A2 Expression vector and methods of producing high levels of proteins |
03/05/2008 | EP1893756A2 Elimination of n-glycolylneuraminic acid from mammalian products for human use |
03/05/2008 | EP1893754A2 Novel glutamic acid decarboxylase (gad) chimera and methods of use |
03/05/2008 | EP1893750A1 Amniotic cells and methods for use thereof |
03/05/2008 | EP1893749A1 Reporter hepatocytes and other cells for drug screening and toxicity testing |
03/05/2008 | EP1893650A2 Hiv tat-cd4 hybried molecules and methods of use thereof |
03/05/2008 | EP1893645A1 Optimization of west nile virus antibodies |
03/05/2008 | EP1893641A2 Mutants of human app and their use for the production of transgenic animals |
03/05/2008 | EP1893638A2 Insect-specific protease recognition sequences |